VUMC in the news, Jan. 9, 2024

Study finds significant increased risk of future health issues for youth who suffer nonfatal firearm injuries

A Vanderbilt study found that youth who suffer nonfatal firearm injuries have a significantly increased risk of hospitalizations, emergency department visits, outpatient visits and costs in the 12 months following injury compared to youth without a firearm injury.

Potential AML therapy induces leukemic stem cell death

Vanderbilt researchers are studying a potential therapy for acute myeloid leukemia that targets the residual leukemic stem cells in bone marrow after treatment that are responsible for relapses and drug resistance.

C.J. Stimson named Executive Vice President for Population Health

C.J. Stimson, MD, JD, assistant professor of Urology and Senior Vice President of Value Transformation in the Vanderbilt University Medical Center Office of Population Health, has been named Executive Vice President for Population Health.

David Posch assumes new role of Senior Vice President for Business Consulting

David Posch, MA, Executive Vice President for Vanderbilt University Medical Center’s (VUMC) Office of Population Health and Executive Director for Vanderbilt Health Affiliated Network (VHAN), has transitioned into the new role of Senior Vice President for Business Consulting

Team uses COVID-19 to test automated acute disease profiling

An automated solution for creating phenotyping algorithms, PheNorm, worked well to identify symptomatic COVID-19 cases in electronic health records, suggesting that automation could speed high-throughput phenotyping of acute disease.